Titre : | A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015 [Viewpoint] (2016) |
Auteurs : | M. L. NOLAN ; B. ALLEN ; H. V. KUNINS ; D. PAONE |
Type de document : | Article : Périodique |
Dans : | International Journal of Drug Policy (Vol.34, August 2016) |
Article en page(s) : | 101-103 |
Langues: | Anglais |
Discipline : | SAN (Santé publique / Public health) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés CANNABINOIDES ; DROGUES DE SYNTHESE ; MORBIDITE ; URGENCE ; TOXICOLOGIE ; URINE ; SANTE PUBLIQUE |
Résumé : | Despite continued prohibition of most drugs for recreational use, drug use is common in the United States. In 2013, nearly half of adults aged 12 years and older reported lifetime use of illicit drugs (47%), with 44% reporting lifetime cannabis use (SAMHSA, 2014a). However, US federal law prohibits the manufacture, possession, sale, or consumption of cannabis. In addition, products containing a variety of synthetic cannabinoids (SCs), many of which are not controlled, have emerged in recent years. SCs include chemical compounds that bind to cannabinoid receptors in the brain (Brents and Prather, 2014 and Gurney et al., 2014). [Extract] |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, Queens, NY, USA |
Cote : | Abonnement |
Accueil